0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single-ingredient Codeine Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-21X10951
Home | Market Reports | Health| Health Conditions| Pain Management
Global Single ingredient Codeine Market Research Report 2022
BUY CHAPTERS

Global Single-ingredient Codeine Market Research Report 2025

Code: QYRE-Auto-21X10951
Report
February 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Single-ingredient Codeine Market Size

The global market for Single-ingredient Codeine was valued at US$ 71.5 million in the year 2024 and is projected to reach a revised size of US$ 48.4 million by 2031, growing at a CAGR of -5.5% during the forecast period.

Single-ingredient Codeine Market

Single-ingredient Codeine Market

Single-ingredient codeine is approved for pain management in adults only. Also used to reduce coughing. It is frequently combined with promethazine in prescription cough-and-cold medicines and with other cold remedies in over-the-counter (OTC) preparations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Single-ingredient Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-ingredient Codeine.
The Single-ingredient Codeine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single-ingredient Codeine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-ingredient Codeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Single-ingredient Codeine Market Report

Report Metric Details
Report Name Single-ingredient Codeine Market
Accounted market size in year US$ 71.5 million
Forecasted market size in 2031 US$ 48.4 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Mylan, Aristo Pharma GmbH, Lannett Company, Laboratoire Riva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Single-ingredient Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Single-ingredient Codeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Single-ingredient Codeine Market size in 2031?

Ans: The Single-ingredient Codeine Market size in 2031 will be US$ 48.4 million.

Who are the main players in the Single-ingredient Codeine Market report?

Ans: The main players in the Single-ingredient Codeine Market are Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Mylan, Aristo Pharma GmbH, Lannett Company, Laboratoire Riva

What are the Application segmentation covered in the Single-ingredient Codeine Market report?

Ans: The Applications covered in the Single-ingredient Codeine Market report are Narcotic Analgesic, Antitussive, Others

What are the Type segmentation covered in the Single-ingredient Codeine Market report?

Ans: The Types covered in the Single-ingredient Codeine Market report are Ordinary Tablet, Sustained Release Tablets

Recommended Reports

Pain and Analgesics

OTC & Cold Remedies

APIs & Drug Manufacturing

1 Single-ingredient Codeine Market Overview
1.1 Product Definition
1.2 Single-ingredient Codeine by Type
1.2.1 Global Single-ingredient Codeine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ordinary Tablet
1.2.3 Sustained Release Tablets
1.3 Single-ingredient Codeine by Application
1.3.1 Global Single-ingredient Codeine Market Value by Application (2024 VS 2031)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Single-ingredient Codeine Market Size Estimates and Forecasts
1.4.1 Global Single-ingredient Codeine Revenue 2020-2031
1.4.2 Global Single-ingredient Codeine Sales 2020-2031
1.4.3 Global Single-ingredient Codeine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Single-ingredient Codeine Market Competition by Manufacturers
2.1 Global Single-ingredient Codeine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Single-ingredient Codeine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Single-ingredient Codeine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Single-ingredient Codeine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Single-ingredient Codeine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Single-ingredient Codeine, Product Type & Application
2.7 Global Key Manufacturers of Single-ingredient Codeine, Date of Enter into This Industry
2.8 Global Single-ingredient Codeine Market Competitive Situation and Trends
2.8.1 Global Single-ingredient Codeine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Single-ingredient Codeine Players Market Share by Revenue
2.8.3 Global Single-ingredient Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Single-ingredient Codeine Market Scenario by Region
3.1 Global Single-ingredient Codeine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Single-ingredient Codeine Sales by Region: 2020-2031
3.2.1 Global Single-ingredient Codeine Sales by Region: 2020-2025
3.2.2 Global Single-ingredient Codeine Sales by Region: 2026-2031
3.3 Global Single-ingredient Codeine Revenue by Region: 2020-2031
3.3.1 Global Single-ingredient Codeine Revenue by Region: 2020-2025
3.3.2 Global Single-ingredient Codeine Revenue by Region: 2026-2031
3.4 North America Single-ingredient Codeine Market Facts & Figures by Country
3.4.1 North America Single-ingredient Codeine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Single-ingredient Codeine Sales by Country (2020-2031)
3.4.3 North America Single-ingredient Codeine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Single-ingredient Codeine Market Facts & Figures by Country
3.5.1 Europe Single-ingredient Codeine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Single-ingredient Codeine Sales by Country (2020-2031)
3.5.3 Europe Single-ingredient Codeine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single-ingredient Codeine Market Facts & Figures by Region
3.6.1 Asia Pacific Single-ingredient Codeine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Single-ingredient Codeine Sales by Region (2020-2031)
3.6.3 Asia Pacific Single-ingredient Codeine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Single-ingredient Codeine Market Facts & Figures by Country
3.7.1 Latin America Single-ingredient Codeine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Single-ingredient Codeine Sales by Country (2020-2031)
3.7.3 Latin America Single-ingredient Codeine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Single-ingredient Codeine Market Facts & Figures by Country
3.8.1 Middle East and Africa Single-ingredient Codeine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Single-ingredient Codeine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Single-ingredient Codeine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Single-ingredient Codeine Sales by Type (2020-2031)
4.1.1 Global Single-ingredient Codeine Sales by Type (2020-2025)
4.1.2 Global Single-ingredient Codeine Sales by Type (2026-2031)
4.1.3 Global Single-ingredient Codeine Sales Market Share by Type (2020-2031)
4.2 Global Single-ingredient Codeine Revenue by Type (2020-2031)
4.2.1 Global Single-ingredient Codeine Revenue by Type (2020-2025)
4.2.2 Global Single-ingredient Codeine Revenue by Type (2026-2031)
4.2.3 Global Single-ingredient Codeine Revenue Market Share by Type (2020-2031)
4.3 Global Single-ingredient Codeine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Single-ingredient Codeine Sales by Application (2020-2031)
5.1.1 Global Single-ingredient Codeine Sales by Application (2020-2025)
5.1.2 Global Single-ingredient Codeine Sales by Application (2026-2031)
5.1.3 Global Single-ingredient Codeine Sales Market Share by Application (2020-2031)
5.2 Global Single-ingredient Codeine Revenue by Application (2020-2031)
5.2.1 Global Single-ingredient Codeine Revenue by Application (2020-2025)
5.2.2 Global Single-ingredient Codeine Revenue by Application (2026-2031)
5.2.3 Global Single-ingredient Codeine Revenue Market Share by Application (2020-2031)
5.3 Global Single-ingredient Codeine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Company Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Taiji Single-ingredient Codeine Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Company Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mallinckrodt Single-ingredient Codeine Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Single-ingredient Codeine Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Single-ingredient Codeine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Company Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medreich Single-ingredient Codeine Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Company Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Aventis Single-ingredient Codeine Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Single-ingredient Codeine Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Company Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Single-ingredient Codeine Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Company Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pharmaceutical Associates Single-ingredient Codeine Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Single-ingredient Codeine Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Company Information
6.11.2 Apotex Description and Business Overview
6.11.3 Apotex Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Apotex Single-ingredient Codeine Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Company Information
6.12.2 Mylan Description and Business Overview
6.12.3 Mylan Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mylan Single-ingredient Codeine Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Company Information
6.13.2 Aristo Pharma GmbH Description and Business Overview
6.13.3 Aristo Pharma GmbH Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aristo Pharma GmbH Single-ingredient Codeine Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Company Information
6.14.2 Lannett Company Description and Business Overview
6.14.3 Lannett Company Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lannett Company Single-ingredient Codeine Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Company Information
6.15.2 Laboratoire Riva Description and Business Overview
6.15.3 Laboratoire Riva Single-ingredient Codeine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Laboratoire Riva Single-ingredient Codeine Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single-ingredient Codeine Industry Chain Analysis
7.2 Single-ingredient Codeine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single-ingredient Codeine Production Mode & Process Analysis
7.4 Single-ingredient Codeine Sales and Marketing
7.4.1 Single-ingredient Codeine Sales Channels
7.4.2 Single-ingredient Codeine Distributors
7.5 Single-ingredient Codeine Customer Analysis
8 Single-ingredient Codeine Market Dynamics
8.1 Single-ingredient Codeine Industry Trends
8.2 Single-ingredient Codeine Market Drivers
8.3 Single-ingredient Codeine Market Challenges
8.4 Single-ingredient Codeine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Single-ingredient Codeine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Single-ingredient Codeine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Single-ingredient Codeine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Single-ingredient Codeine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Single-ingredient Codeine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Single-ingredient Codeine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Single-ingredient Codeine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Single-ingredient Codeine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Single-ingredient Codeine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Single-ingredient Codeine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Single-ingredient Codeine, Product Type & Application
 Table 12. Global Key Manufacturers of Single-ingredient Codeine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Single-ingredient Codeine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single-ingredient Codeine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Single-ingredient Codeine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Single-ingredient Codeine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Single-ingredient Codeine Sales Market Share by Region (2020-2025)
 Table 19. Global Single-ingredient Codeine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Single-ingredient Codeine Sales Market Share by Region (2026-2031)
 Table 21. Global Single-ingredient Codeine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Single-ingredient Codeine Revenue Market Share by Region (2020-2025)
 Table 23. Global Single-ingredient Codeine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Single-ingredient Codeine Revenue Market Share by Region (2026-2031)
 Table 25. North America Single-ingredient Codeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Single-ingredient Codeine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Single-ingredient Codeine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Single-ingredient Codeine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Single-ingredient Codeine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Single-ingredient Codeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Single-ingredient Codeine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Single-ingredient Codeine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Single-ingredient Codeine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Single-ingredient Codeine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Single-ingredient Codeine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Single-ingredient Codeine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Single-ingredient Codeine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Single-ingredient Codeine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Single-ingredient Codeine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Single-ingredient Codeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Single-ingredient Codeine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Single-ingredient Codeine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Single-ingredient Codeine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Single-ingredient Codeine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Single-ingredient Codeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Single-ingredient Codeine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Single-ingredient Codeine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Single-ingredient Codeine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Single-ingredient Codeine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Single-ingredient Codeine Sales (K Units) by Type (2020-2025)
 Table 51. Global Single-ingredient Codeine Sales (K Units) by Type (2026-2031)
 Table 52. Global Single-ingredient Codeine Sales Market Share by Type (2020-2025)
 Table 53. Global Single-ingredient Codeine Sales Market Share by Type (2026-2031)
 Table 54. Global Single-ingredient Codeine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Single-ingredient Codeine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Single-ingredient Codeine Revenue Market Share by Type (2020-2025)
 Table 57. Global Single-ingredient Codeine Revenue Market Share by Type (2026-2031)
 Table 58. Global Single-ingredient Codeine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Single-ingredient Codeine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Single-ingredient Codeine Sales (K Units) by Application (2020-2025)
 Table 61. Global Single-ingredient Codeine Sales (K Units) by Application (2026-2031)
 Table 62. Global Single-ingredient Codeine Sales Market Share by Application (2020-2025)
 Table 63. Global Single-ingredient Codeine Sales Market Share by Application (2026-2031)
 Table 64. Global Single-ingredient Codeine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Single-ingredient Codeine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Single-ingredient Codeine Revenue Market Share by Application (2020-2025)
 Table 67. Global Single-ingredient Codeine Revenue Market Share by Application (2026-2031)
 Table 68. Global Single-ingredient Codeine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Single-ingredient Codeine Price (US$/Unit) by Application (2026-2031)
 Table 70. Taiji Company Information
 Table 71. Taiji Description and Business Overview
 Table 72. Taiji Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Taiji Single-ingredient Codeine Product
 Table 74. Taiji Recent Developments/Updates
 Table 75. Mallinckrodt Company Information
 Table 76. Mallinckrodt Description and Business Overview
 Table 77. Mallinckrodt Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mallinckrodt Single-ingredient Codeine Product
 Table 79. Mallinckrodt Recent Developments/Updates
 Table 80. TEVA Company Information
 Table 81. TEVA Description and Business Overview
 Table 82. TEVA Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TEVA Single-ingredient Codeine Product
 Table 84. TEVA Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Single-ingredient Codeine Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Medreich Company Information
 Table 91. Medreich Description and Business Overview
 Table 92. Medreich Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Medreich Single-ingredient Codeine Product
 Table 94. Medreich Recent Developments/Updates
 Table 95. Sanofi Aventis Company Information
 Table 96. Sanofi Aventis Description and Business Overview
 Table 97. Sanofi Aventis Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi Aventis Single-ingredient Codeine Product
 Table 99. Sanofi Aventis Recent Developments/Updates
 Table 100. Cipla Company Information
 Table 101. Cipla Description and Business Overview
 Table 102. Cipla Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cipla Single-ingredient Codeine Product
 Table 104. Cipla Recent Developments/Updates
 Table 105. Hikma Company Information
 Table 106. Hikma Description and Business Overview
 Table 107. Hikma Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hikma Single-ingredient Codeine Product
 Table 109. Hikma Recent Developments/Updates
 Table 110. Pharmaceutical Associates Company Information
 Table 111. Pharmaceutical Associates Description and Business Overview
 Table 112. Pharmaceutical Associates Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pharmaceutical Associates Single-ingredient Codeine Product
 Table 114. Pharmaceutical Associates Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis Single-ingredient Codeine Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Apotex Company Information
 Table 121. Apotex Description and Business Overview
 Table 122. Apotex Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Apotex Single-ingredient Codeine Product
 Table 124. Apotex Recent Developments/Updates
 Table 125. Mylan Company Information
 Table 126. Mylan Description and Business Overview
 Table 127. Mylan Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Mylan Single-ingredient Codeine Product
 Table 129. Mylan Recent Developments/Updates
 Table 130. Aristo Pharma GmbH Company Information
 Table 131. Aristo Pharma GmbH Description and Business Overview
 Table 132. Aristo Pharma GmbH Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Aristo Pharma GmbH Single-ingredient Codeine Product
 Table 134. Aristo Pharma GmbH Recent Developments/Updates
 Table 135. Lannett Company Company Information
 Table 136. Lannett Company Description and Business Overview
 Table 137. Lannett Company Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Lannett Company Single-ingredient Codeine Product
 Table 139. Lannett Company Recent Developments/Updates
 Table 140. Laboratoire Riva Company Information
 Table 141. Laboratoire Riva Description and Business Overview
 Table 142. Laboratoire Riva Single-ingredient Codeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Laboratoire Riva Single-ingredient Codeine Product
 Table 144. Laboratoire Riva Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Single-ingredient Codeine Distributors List
 Table 148. Single-ingredient Codeine Customers List
 Table 149. Single-ingredient Codeine Market Trends
 Table 150. Single-ingredient Codeine Market Drivers
 Table 151. Single-ingredient Codeine Market Challenges
 Table 152. Single-ingredient Codeine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Single-ingredient Codeine
 Figure 2. Global Single-ingredient Codeine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Single-ingredient Codeine Market Share by Type: 2024 & 2031
 Figure 4. Ordinary Tablet Product Picture
 Figure 5. Sustained Release Tablets Product Picture
 Figure 6. Global Single-ingredient Codeine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Single-ingredient Codeine Market Share by Application: 2024 & 2031
 Figure 8. Narcotic Analgesic
 Figure 9. Antitussive
 Figure 10. Others
 Figure 11. Global Single-ingredient Codeine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Single-ingredient Codeine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Single-ingredient Codeine Sales (2020-2031) & (K Units)
 Figure 14. Global Single-ingredient Codeine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Single-ingredient Codeine Report Years Considered
 Figure 16. Single-ingredient Codeine Sales Share by Manufacturers in 2024
 Figure 17. Global Single-ingredient Codeine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Single-ingredient Codeine Players: Market Share by Revenue in Single-ingredient Codeine in 2024
 Figure 19. Single-ingredient Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Single-ingredient Codeine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Single-ingredient Codeine Sales Market Share by Country (2020-2031)
 Figure 22. North America Single-ingredient Codeine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Single-ingredient Codeine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Single-ingredient Codeine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Single-ingredient Codeine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Single-ingredient Codeine Revenue Market Share by Region (2020-2031)
 Figure 34. China Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Single-ingredient Codeine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Single-ingredient Codeine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Single-ingredient Codeine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Single-ingredient Codeine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Single-ingredient Codeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Single-ingredient Codeine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Single-ingredient Codeine by Type (2020-2031)
 Figure 55. Global Single-ingredient Codeine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Single-ingredient Codeine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Single-ingredient Codeine by Application (2020-2031)
 Figure 58. Global Single-ingredient Codeine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Single-ingredient Codeine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona